Resultats globals: 89 registres trobats en 0.04 segons.
Articles, 78 registres trobats
Documents de recerca, 11 registres trobats
Articles 78 registres trobats  1 - 10següentfinal  anar al registre:
1.
8 p, 422.0 KB Concordance between two methods in measuring treatment adherence in patients with type 2 diabetes / López-Simarro, Flora (Institut Català de la Salut) ; Brotons, Carlos (Institut d'Investigació Biomèdica Sant Pau) ; Moral Peláez, Irene (Institut d'Investigació Biomèdica Sant Pau) ; Aguado-Jodar, Alba (CAP Sagrada Família) ; Cols-Sagarra, Cèlia (Institut Català de la Salut) ; Miravet-Jiménez, Sònia (Institut Català de la Salut) ; Universitat Autònoma de Barcelona
We analyzed the concordance between two methods for measuring treatment adherence (TA) and studied the determinants of TA in patients with type 2 diabetes mellitus. We conducted a cross-sectional descriptive study in a primary care center, involving 320 diabetic patients. [...]
2016 - 10.2147/PPA.S105073
Patient preference and adherence, Vol. 10 (april 2016) , p. 743-750  
2.
1 p, 341.5 KB Erratum : CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol [BMC Pregnancy Childbirth., 16, (2016) (167)] doi: 10.1186/s12884-016-0961-5 / Feig, D.S. (Mt. Sinai Hospital) ; Asztalos, Elizabeth (Sunnybrook Research Institute) ; Corcoy i Pla, Rosa (Institut d'Investigació Biomèdica Sant Pau) ; De Leiva, A. (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Donovan, L. (Alberta Health Services) ; Hod, M. (Helen Schneider Hospital for Women) ; Jovanovic, L. ; Keely, E. (The Ottawa Hospital) ; Kollman, C. (Jaeb Center For Health Research) ; McManus, R. (St. Joseph's Health Centre) ; Murphy, K. (Lunenfeld-Tanenbaum Research Institute) ; Ruedy, K. (Jaeb Center For Health Research) ; Sanchez, J.J. (Sunnybrook Research Institute) ; Tomlinson, G. (Toronto General Hospital) ; Murphy, H. R. (Norwich Medical School) ; Cleave, B. (Mt Sinai Hospital) ; Donat, D. (Mt Sinai Hospital) ; Gandhi, S. (Mt Sinai Hospital) ; Strom, M. (Mt Sinai Hospital) ; Chico Ballesteros, Ana (Institut d'Investigació Biomèdica Sant Pau) ; José Martínez, M. (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Sánchez, M. (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Tundidor, D. (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Amiel, Stephanie (King's College Hospital NHS Foundation Trust) ; Hunt, K. (King's College Hospital NHS Foundation Trust) ; Green, L. (King's College Hospital NHS Foundation Trust) ; Rogers, H. (King's College Hospital NHS Foundation Trust) ; Rossi, B. (King's College Hospital NHS Foundation Trust) ; Stodhart, B. (King's College Hospital NHS Foundation Trust) ; Bonomo, M. (Niguarda ca' Granda Hospital) ; Bertuzzi, F. (Niguarda ca' Granda Hospital) ; Corica, G.D. (Niguarda ca' Granda Hospital) ; Fazio, S. (Niguarda ca' Granda Hospital) ; Giro, R. (Niguarda ca' Granda Hospital) ; Mion, E. (Niguarda ca' Granda Hospital) ; Moletta, A. (Niguarda ca' Granda Hospital) ; Pintaudi, B. (Niguarda ca' Granda Hospital) ; Sorrentino, R. (Niguarda ca' Granda Hospital) ; Booth, J. (McMaster University (Canadà)) ; McInnes, N. (McMaster University (Canadà)) ; Nykamp, A. (McMaster University (Canadà)) ; Otto, R. (McMaster University (Canadà)) ; Smith, A. (McMaster University (Canadà)) ; Stanton, I. (McMaster University (Canadà)) ; Tazzeo, T. (McMaster University (Canadà)) ; Oldford, C. (University of Calgary) ; Young, C. (University of Calgary) ; Gougeon, C. (University of Calgary) ; Houlden, R. (Queen's University) ; Breen, A. (Queen's University) ; Castorino, K. (Diabetes Center) ; Sansum, W. (Diabetes Center) ; Erin Keely, None (The Ottawa Hospital General Campus) ; Clark, H. (The Ottawa Hospital General Campus) ; Gaudet, L. (The Ottawa Hospital General Campus) ; Karovitch, A. (The Ottawa Hospital General Campus) ; Malcolm, Janine (The Ottawa Hospital General Campus) ; Lowe, J. (Sunnybrook Health Sciences Centre (Toronto)) ; Rogowsky, A. (Sunnybrook Health Sciences Centre (Toronto)) ; Kudirka, A. (St. Joseph's Health Centre) ; Watson, M. (St. Joseph's Health Centre) ; Morris, D. (Ipswich Hospital NHS Trust) ; Farnworth, F. (Ipswich Hospital NHS Trust) ; Fowler, D. (Ipswich Hospital NHS Trust) ; Mitchell, S. (Ipswich Hospital NHS Trust) ; Rosier, J. (Ipswich Hospital NHS Trust) ; Murphy, H. (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Byrne, C. (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Davenport, K. (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Grisoni, J. (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Mulrennan, S. (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Neoh, S. (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; O'Sullivan, E. (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Simmons, D. (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Stewart, Z. (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Templin, H. (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Helen Murphy, None (Norfolk and Norwich University Hospital) ; Turner, J. (Norfolk and Norwich University Hospital) ; Canciani, G. (Norfolk and Norwich University Hospital) ; Hewapathirana, N. (Norfolk and Norwich University Hospital) ; Jones, L. (Norfolk and Norwich University Hospital) ; Piper, L. (Norfolk and Norwich University Hospital) ; Temple, R. (Norfolk and Norwich University Hospital) ; Wallace, T. (Norfolk and Norwich University Hospital) ; Maitland, R. (Guys and St Thomas' NHS Foundation Trust) ; Banerjee, A. (Guys and St Thomas' NHS Foundation Trust) ; Briley, A. (Guys and St Thomas' NHS Foundation Trust) ; Brackenridge, A. (Guys and St Thomas' NHS Foundation Trust) ; Gilby, P. (Guys and St Thomas' NHS Foundation Trust) ; Gill, C. (Guys and St Thomas' NHS Foundation Trust) ; Reid, A. (Guys and St Thomas' NHS Foundation Trust) ; Singh, C. (Guys and St Thomas' NHS Foundation Trust) ; White, S. (Guys and St Thomas' NHS Foundation Trust) ; Wolfs, M. (St. Michael's Hospital) ; Scott, E. (Leeds Teaching Hospitals NHS Trust) ; Endersby, D. (Leeds Teaching Hospitals NHS Trust) ; Maresh, M. (Central Manchester University Hospitals NHS Foundation Trust) ; Kearney, G. (Central Manchester University Hospitals NHS Foundation Trust) ; Morris, J. (Central Manchester University Hospitals NHS Foundation Trust) ; Quinn, S. (Central Manchester University Hospitals NHS Foundation Trust) ; Rao-Balakrishna, P. (Central Manchester University Hospitals NHS Foundation Trust) ; MacDougall, M. (Royal Victoria Infirmary) ; Bilous, R. (South Tees Hospitals. NHS Foundation Trust) ; Bilous, M. (South Tees Hospitals. NHS Foundation Trust) ; Mahadissu, S. (South Tees Hospitals. NHS Foundation Trust) ; Menini, D. (South Tees Hospitals. NHS Foundation Trust) ; Mukhtar, R. (South Tees Hospitals. NHS Foundation Trust) ; Holt, R. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Forbes, J. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Martin, N. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Walbridge, F. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Mansell, P. (Queen's Medical Centre) ; Babington, G. (Queen's Medical Centre) ; Bugg, G. (Queen's Medical Centre) ; Gazis, T. (Queen's Medical Centre) ; Nia Jones, None (Queen's Medical Centre) ; Spick, D. (Queen's Medical Centre) ; Heller, S. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Bustani, R. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Gordon, V. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Madhuvrata, P. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Hudson, S. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Nisbet, C. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Novodvorsky, P. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Solomon, A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Towse, K. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Philip, S. (Grampian Diabetes Centre) ; Booth, A. (Grampian Diabetes Centre) ; Cadzow, A. (Grampian Diabetes Centre) ; Chlost, M. (Grampian Diabetes Centre) ; Murray, L. (Grampian Diabetes Centre) ; Karen Norris, None (Grampian Diabetes Centre) ; Shearer, K. (Grampian Diabetes Centre) ; Dover, A. (Royal Infirmary of Edinburgh) ; Dougherty, F. (Royal Infirmary of Edinburgh) ; Johnston, S. (Royal Infirmary of Edinburgh) ; Little, J. (Royal Infirmary of Edinburgh) ; McKay, L. (Royal Infirmary of Edinburgh) ; Lindsay, R. (Glasgow Royal Infirmary) ; Carty, D. (Glasgow Royal Infirmary) ; Crawford, I. (Glasgow Royal Infirmary) ; Mackenzie, F. (Glasgow Royal Infirmary) ; McSorley, T. (Glasgow Royal Infirmary) ; Dunne, F. (Galway University Hospitals) ; Brosnan, E. (Galway University Hospitals) ; Conway, S. (Galway University Hospitals) ; Byrnes, M.C. (Galway University Hospitals) ; Duane, L. (Galway University Hospitals) ; Duffy, N. (Galway University Hospitals) ; Egan, A. (Galway University Hospitals) ; Gaffney, G. (Galway University Hospitals) ; Higgins, G. (Galway University Hospitals) ; Kelly, C. (Galway University Hospitals) ; Kirwan, C. (Galway University Hospitals) ; Liew, A. (Galway University Hospitals) ; Normoyle, K. (Galway University Hospitals) ; Roarty, C. (Galway University Hospitals) ; Waldron, M. (Galway University Hospitals) ; Weisnagel, J. (Centre hospitalier universitaire de Québec) ; Allen, C. (Centre hospitalier universitaire de Québec) ; D'Amours, M. (Centre hospitalier universitaire de Québec) ; Dubé, M.C. (Centre hospitalier universitaire de Québec) ; Julien, V.E. (Centre hospitalier universitaire de Québec) ; Godbout, A. (Hôpital St. Luc) ; Daigle, S. (Hôpital St. Luc) ; Ransom, T. (Izaak Walton Killam Health Sciences Centre (IWK)) ; Coolen, J. (Izaak Walton Killam Health Sciences Centre (IWK)) ; Baxendale, D. (Izaak Walton Killam Health Sciences Centre (IWK)) ; Newstead-Angel, J. (Royal University Hospital) ; Soloman, A.L. (Russells Hall Hospital) ; Gorton, K. (Russells Hall Hospital) ; Jackson, M. (Russells Hall Hospital) ; Miller, K. (Russells Hall Hospital) ; Taylor, J. (Russells Hall Hospital) ; Mergler, S. (The Centre for Mother. Infant and Child Research (CMICR)) ; Qureshi, A. (The Centre for Mother. Infant and Child Research (CMICR)) ; Rodriguez, A. (The Centre for Mother. Infant and Child Research (CMICR)) ; Mangoff, K. (The Centre for Mother. Infant and Child Research (CMICR)) ; Universitat Autònoma de Barcelona
After publication of the original article [1], it came to the authors' attention that an incorrect affiliation was inadvertently added in the Acknowledgements section for the CONCEPTT Collaborative Group. [...]
2016 - 10.1186/s12884-016-1036-3
BMC Pregnancy and Childbirth, Vol. 16 Núm. 1 (26 2016) , p. 249  
3.
8 p, 697.1 KB CONCEPTT : Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol / Feig, Denice S. (Mt Sinai Hospital) ; Asztalos, Elizabeth (Sunnybrook Research Institute) ; Corcoy i Pla, Rosa (Institut d'Investigació Biomèdica Sant Pau) ; De Leiva, Alberto (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Donovan, Lois (Alberta Health Services) ; Hod, Moshe (Helen Schneider Hospital for Women) ; Jovanovic, Lois ; Keely, Erin (The Ottawa Hospital) ; Kollman, Craig (Jaeb Center For Health Research) ; McManus, Ruth (St. Joseph's Health Centre) ; Murphy, Kellie (Lunenfeld-Tanenbaum Research Institute) ; Ruedy, Katrina (Jaeb Center For Health Research) ; Sanchez, J.Johanna (Sunnybrook Research Institute) ; Tomlinson, George (Toronto General Hospital) ; Murphy, Helen R. (Norwich Medical School) ; Cleave, Barbara (Mt Sinai Hospital) ; Donat, Diane (Mt Sinai Hospital) ; Gandhi, Shital (Mt Sinai Hospital) ; Strom, Michelle (Mt Sinai Hospital) ; Chico Ballesteros, Ana (Institut d'Investigació Biomèdica Sant Pau) ; José Martínez, Mª (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Sánchez, Mireia (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Tundidor, Diana (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Amiel, Stephanie (King's College Hospital NHS Foundation Trus) ; Hunt, Katharine (King's College Hospital NHS Foundation Trust) ; Green, Louisa (King's College Hospital NHS Foundation Trust) ; Rogers, Helen (King's College Hospital NHS Foundation Trust) ; Rossi, Benedetta (King's College Hospital NHS Foundation Trust) ; Stodhart, Ben (King's College Hospital NHS Foundation Trust) ; Bonomo, Matteo (Niguarda ca' Granda Hospital) ; Bertuzzi, Federico (Niguarda ca' Granda Hospital) ; Corica, Giuseppina D. (Niguarda ca' Granda Hospital) ; Fazio, Silvana (Niguarda ca' Granda Hospital) ; Giro, Ropberto (Niguarda ca' Granda Hospital) ; Mion, Elena (Niguarda ca' Granda Hospital) ; Moletta, Andrea (Niguarda ca' Granda Hospital) ; Pintaudi, Basilio (Niguarda ca' Granda Hospital) ; Sorrentino, Rosa (Niguarda ca' Granda Hospital) ; Booth, John (McMaster University (Canadà)) ; McInnes, Natalia (McMaster University (Canadà)) ; Nykamp, Adelle (McMaster University (Canadà)) ; Otto, Rose (McMaster University (Canadà)) ; Smith, Ada (McMaster University (Canadà)) ; Stanton, Irene (McMaster University (Canadà)) ; Tazzeo, Tracy (McMaster University (Canadà)) ; Oldford, Carolyn (University of Calgary) ; Young, Catherine (University of Calgary) ; Gougeon, Claire (University of Calgary) ; Houlden, Robyn (Queen's University) ; Breen, Adriana (Queen's University) ; Castorino, Kristin (Diabetes Center) ; Sansum, William (Diabetes Center) ; Erin Keely, None (The Ottawa Hospital General Campus) ; Clark, Heather (The Ottawa Hospital General Campus) ; Gaudet, Laura (The Ottawa Hospital General Campus) ; Karovitch, Alan (The Ottawa Hospital General Campus) ; Malcolm, Janine (The Ottawa Hospital General Campus) ; Lowe, Julia (Sunnybrook Health Sciences Centre (Toronto)) ; Rogowsky, Anna (Sunnybrook Health Sciences Centre (Toronto)) ; Kudirka, Anne (St. Joseph's Health Centre) ; Watson, Margaret (St. Joseph's Health Centre) ; Morris, Damian (Ipswich Hospital NHS Trust) ; Farnworth, Frances (Ipswich Hospital NHS Trust) ; Fowler, Duncan (Ipswich Hospital NHS Trust) ; Mitchell, Sue (Ipswich Hospital NHS Trust) ; Rosier, Josephine (Ipswich Hospital NHS Trust) ; Murphy, Helen (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Byrne, Caroline (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Davenport, Katy (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Grisoni, Jeannie (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Mulrennan, Sandra (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Neoh, Sandra (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; O'Sullivan, Esther (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Simmons, David (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Stewart, Zoe (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Templin, Heike (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Helen Murphy, None (Norfolk and Norwich University Hospital) ; Turner, Jeremy (Norfolk and Norwich University Hospital) ; Canciani, Gioia (Norfolk and Norwich University Hospital) ; Hewapathirana, Niranjala (Nilu) (Norfolk and Norwich University Hospital) ; Jones, Louise (Norfolk and Norwich University Hospital) ; Piper, Leanne (Norfolk and Norwich University Hospital) ; Temple, Rosemary (Norfolk and Norwich University Hospital) ; Wallace, Tara (Norfolk and Norwich University Hospital) ; Maitland, Rahat (Guys and St Thomas' NHS Foundation Trust) ; Banerjee, Anita (Guys and St Thomas' NHS Foundation Trust) ; Briley, Anette (Guys and St Thomas' NHS Foundation Trust) ; Brackenridge, Anna (Guys and St Thomas' NHS Foundation Trust) ; Gilby, Pam (Guys and St Thomas' NHS Foundation Trust) ; Gill, Carolyn (Guys and St Thomas' NHS Foundation Trust) ; Reid, Anna (Guys and St Thomas' NHS Foundation Trust) ; Singh, Claire (Guys and St Thomas' NHS Foundation Trust) ; White, Sara (Guys and St Thomas' NHS Foundation Trust) ; Wolfs, Maria (St. Michael's Hospital) ; Scott, Eleanor (Leeds Teaching Hospitals NHS Trust) ; Endersby, Del (Leeds Teaching Hospitals NHS Trust) ; Maresh, Michael (Central Manchester University Hospitals NHS Foundation Trust) ; Kearney, Gretta (Central Manchester University Hospitals NHS Foundation Trust) ; Morris, Juliet (Central Manchester University Hospitals NHS Foundation Trust) ; Quinn, Susan (Central Manchester University Hospitals NHS Foundation Trust) ; Rao-Balakrishna, Prasanna (Central Manchester University Hospitals NHS Foundation Trust) ; MacDougall, Malcolm (Royal Victoria Infirmary) ; Bilous, Rudy (South Tees Hospitals. NHS Foundation Trust) ; Bilous, Mary (South Tees Hospitals. NHS Foundation Trust) ; Mahadissu, Shilpa (South Tees Hospitals. NHS Foundation Trust) ; Menini, Deepika (South Tees Hospitals. NHS Foundation Trust) ; Mukhtar, Rasha (South Tees Hospitals. NHS Foundation Trust) ; Holt, Richard (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Forbes, Jane (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Martin, Nicki (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Walbridge, Fiona (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Mansell, Peter (Queen's Medical Centre) ; Babington, Gayna (Queen's Medical Centre) ; Bugg, George (Queen's Medical Centre) ; Gazis, Tasso (Queen's Medical Centre) ; Nia Jones, None (Queen's Medical Centre) ; Spick, Dawn (Queen's Medical Centre) ; Heller, Simon (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Bustani, Rebbeca (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Gordon, Val (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Madhuvrata, Priya (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Hudson, Sue (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Nisbet, Chloe (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Novodvorsky, Peter (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Solomon, Alexandra (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Towse, Karen (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Philip, Sam (Grampian Diabetes Centre) ; Booth, Anne (Grampian Diabetes Centre) ; Cadzow, Ann (Grampian Diabetes Centre) ; Chlost, Martyna (Grampian Diabetes Centre) ; Murray, Lynne (Grampian Diabetes Centre) ; Karen Norris, None (Grampian Diabetes Centre) ; Shearer, K.atrina (Grampian Diabetes Centre) ; Dover, Anna (Royal Infirmary of Edinburgh) ; Dougherty, Frances (Royal Infirmary of Edinburgh) ; Johnston, Susan (Royal Infirmary of Edinburgh) ; Little, Jill (Royal Infirmary of Edinburgh) ; McKay, Liz (Royal Infirmary of Edinburgh) ; Lindsay, Robert (Glasgow Royal Infirmary) ; Carty, David (Glasgow Royal Infirmary) ; Crawford, Isobel (Glasgow Royal Infirmary) ; Mackenzie, Fiona (Glasgow Royal Infirmary) ; McSorley, Therese (Glasgow Royal Infirmary) ; Dunne, Fidelma (Galway University Hospitals) ; Brosnan, Elizabeth (Galway University Hospitals) ; Conway, Sharon (Galway University Hospitals) ; Byrnes, Michelle Courcy (Galway University Hospitals) ; Duane, Linda (Galway University Hospitals) ; Duffy, Niamh (Galway University Hospitals) ; Egan, Aoife (Galway University Hospitals) ; Gaffney, Geraldine (Galway University Hospitals) ; Higgins, Grainne (Galway University Hospitals) ; Kelly, Caroline (Galway University Hospitals) ; Kirwan, Collette (Galway University Hospitals) ; Liew, Aaron (Galway University Hospitals) ; Normoyle, Kevin (Galway University Hospitals) ; Roarty, Christina (Galway University Hospitals) ; Waldron, Mairead (Galway University Hospitals) ; Weisnagel, John (Centre hospitalier universitaire de Québec) ; Allen, Christyne (Centre hospitalier universitaire de Québec) ; D'Amours, Martin (Centre hospitalier universitaire de Québec) ; Dubé, Marie-Christine (Centre hospitalier universitaire de Québec) ; Julien, Valérie-Eve (Centre hospitalier universitaire de Québec) ; Godbout, Ariane (Hôpital St. Luc) ; Daigle, Sylvie (Hôpital St. Luc) ; Ransom, Thomas (Izaak Walton Killam Health Sciences Centre (IWK)) ; Coolen, Jill (Izaak Walton Killam Health Sciences Centre (IWK)) ; Baxendale, Darlene (Izaak Walton Killam Health Sciences Centre (IWK)) ; Newstead-Angel, Jill (Royal University Hospital) ; Soloman, Alexandra L. (Russells Hall Hospital) ; Gorton, Karen (Russells Hall Hospital) ; Jackson, Margaret (Russells Hall Hospital) ; Miller, Kirsty (Russells Hall Hospital) ; Taylor, Julie (Russells Hall Hospital) ; Mergler, Sonya (The Centre for Mother. Infant and Child Research (CMICR)) ; Qureshi, Asma (The Centre for Mother. Infant and Child Research (CMICR)) ; Rodriguez, Adriana (The Centre for Mother. Infant and Child Research (CMICR)) ; Mangoff, Kathryn (The Centre for Mother. Infant and Child Research (CMICR)) ; Universitat Autònoma de Barcelona
Women with type 1 diabetes strive for optimal glycemic control before and during pregnancy to avoid adverse obstetric and perinatal outcomes. For most women, optimal glycemic control is challenging to achieve and maintain. [...]
2016 - 10.1186/s12884-016-0961-5
BMC Pregnancy and Childbirth, Vol. 16 Núm. 1 (18 2016) , p. 167  
4.
17 p, 3.1 MB Effects of a carob-pod-derived sweetener on glucose metabolism / Lambert, Carmen (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Cubedo, Judit (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ; Padró, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; López-Bernal, Sergi (Institut d'Investigació Biomèdica Sant Pau) ; Rocha, Milagros (Hospital Universitari Doctor Peset (València)) ; Hernández-Mijares, Antonio (Universitat de València) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Patients with type 2 diabetes mellitus (T2DM) have a higher incidence of cardiovascular (CV) events. The ingestion of high-glycemic index (GI) diets, specially sweetened beverage consumption, has been associated with the development of T2DM and CV disease. [...]
2018 - 10.3390/nu10030271
Nutrients, Vol. 10 Núm. 3 (march 2018) , p. 271  
5.
13 p, 429.7 KB Association between gestational weight gain, gestational diabetes risk, and obstetric outcomes : A randomized controlled trial post hoc analysis / Simmons, David (Western Sydney University) ; Devlieger, Roland (GasthuisZusters Antwerpen Sint-Augustinus) ; van Assche, Andre (KU Leuven) ; Galjaard, Sander (University Medical Centre Rotterdam) ; Corcoy i Pla, Rosa (Institut d'Investigació Biomèdica Sant Pau) ; Adelantado, Juan M (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Dunne, Fidelma (National University of Ireland) ; Desoye, Gernot (Medizinische Universitaet Graz) ; Kautzky-Willer, Alexandra (Addenbrookes Hospital (Cambridge, Regne Unit)) ; Damm, Peter (University of Copenhagen) ; Mathiesen, Elisabeth R. (University of Copenhagen) ; Jensen, Dorte M. (University of Southern Denmark) ; Andersen, Lise-Lotte (University of Southern Denmark) ; Lapolla, Annunziata (Università degli Studi di Padova) ; Dalfra, Maria Grazia (Università degli Studi di Padova) ; Bertolotto, Alessandra (University of Pisa) ; Wender-Ozegowska, Ewa (Poznan University of Medical Sciences) ; Zawiejska, Agnieszka (Poznan University of Medical Sciences) ; Hill, David (Recherche en Santé Lawson SA) ; Snoek, Frank J. (Vrije Universiteit Amsterdam) ; van Poppel, M.N.M (University of Graz) ; Universitat Autònoma de Barcelona
Excess gestational weight gain (GWG) is associated with the development of gestational diabetes mellitus (GDM). Lifestyle trials have not achieved much GWG limitation, and have largely failed to prevent GDM. [...]
2018 - 10.3390/nu10111568
Nutrients, Vol. 10 Núm. 11 (november 2018) , p. 1568  
6.
18 p, 723.6 KB Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain : A Systematic Literature Review / Núñez, Mercedes (Eli Lilly and Company) ; Díaz, Silvia (Eli Lilly and Company) ; Dilla, Tatiana (Eli Lilly and Company) ; Reviriego, Jesús (Eli Lilly and Company) ; Pérez Pérez, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
To assess the burden of hypoglycemia in patients with diabetes mellitus (DM) in Spain, including epidemiological data and information relating to healthcare resource utilization (HRU) and costs, and patients' quality of life (QoL). [...]
2019 - 10.1007/s13300-019-0563-0
Diabetes Therapy, Vol. 10 Núm. 2 (january 2019) , p. 375-392  
7.
14 p, 1.7 MB Circulating soluble CD36 is similar in type 1 and type 2 diabetes mellitus versus non-diabetic subjects / Castelblanco, Esmeralda (Institut d'Investigació Biomèdica Sant Pau) ; Sanjurjo, Lucía (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Falguera, Mireia (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Hernández, Marta (Hospital Universitari Arnau de Vilanova) ; Fernandez-Real, J.M. (Hospital Universitari de Girona Doctor Josep Trueta) ; Sarrias, Maria-Rosa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Alonso Pedrol, Núria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
The aim of this study was to determine whether plasma concentrations of sCD36 (soluble CD36) are associated with the presence of type 1 or type 2 diabetes. Plasma levels of sCD36 were analysed in 1023 subjects (225 type 1 diabetes (T1D) patients, 276 type 2 diabetes (T2D) patients, and 522 non-diabetic control subjects) using an enzyme-linked immunosorbent assay (ELISA). [...]
2019 - 10.3390/jcm8050710
Journal of clinical medicine, Vol. 8 Núm. 5 (may 2019) , p. 710  
8.
24 p, 1.1 MB Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019 : Benefits and risks of antithrombotic therapy for cardiovascular disease prevention / Walker, Jaqui (International Aspirin Foundation) ; Cattaneo, Marco (Università degli studi di Milano) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Agnelli, Giancarlo (University of Perugia) ; Chan, Andrew T. (Harvard Medical School) ; Lanas, Angel (Universidad de Zaragoza) ; Rocca, Bianca (Catholic University School of Medicine) ; Rothwell, Peter (Centre for the Prevention of Stroke and Dementia) ; Patrignani, Paola ('G.d'Annunizio' University) ; Langley, Ruth (MRC Clinical Trials Unit at UCL) ; Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Cosentino, Francesco (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Universitat Autònoma de Barcelona
At the 2019 International Aspirin Foundation Scientific Conference 'Benefits and Risks of Antithrombotic Therapy for Cardiovascular Disease Prevention', held in Rome, Italy, international experts sought to discuss and debate the optimal antithrombotic strategy for the secondary prevention of cardiovascular disease (CVD) and to seek agreement around dosing and target populations for aspirin use in primary disease prevention. [...]
2020 - 10.3332/ECANCER.2019.998
ecancermedicalscience, Vol. 14 (13 2020) , p. 998  
9.
12 p, 617.6 KB Diabetes Does Not Increase the Risk of Hospitalization Due to COVID-19 in Patients Aged 50 Years or Older in Primary Care-APHOSDIAB-COVID-19 Multicenter Study / Orozco-Beltrán, Domingo (Universidad Miguel Hernández. Departamento de Medicina Clínica) ; Merino-Torres, Juan Francisco (Universidad de Valencia. Hospital Universitari i Politècnic La Fe. Servicio de Endocrinología y Nutrición) ; Pérez Pérez, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Cebrián-Cuenca, Ana M (Primary Care Research Group. Biomedical Research Institute of Murcia) ; Párraga-Martínez, Ignacio (Health Center Zone VIII. Servicio de Salud Castilla la Mancha) ; Ávila Lachica, Luis (Consultorio de Almáchar. UGC Vélez Norte) ; Rojo-Martínez, G (Instituto de Investigación Biomédica de Málaga) ; Pomares-Gómez, Francisco J. (Plan de Diabetes Mellitus de la Comunidad Valenciana. Hospital Universitario San Juan de Alicante) ; Álvarez-Guisasola, Fernando (Centro de Salud Ribera de Órbigo. Consejería de Salud Castilla León) ; Sánchez-Molla, Manuel (Médico de Familia. Hospital General Universitario de Elche) ; Gutiérrez, Felix (Centro de Investigación Biomédica en Red Enfermedades Infecciosas) ; Ortega, Francisco J. (Centro Salud Campos Lampreana. Consejería de Salud Castilla y León) ; Mata-Cases, Manel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol. Grup DAP-Cat. Unitat de Suport a la Recerca) ; Carretero Anibarro, Enrique (Centro de Salud José Gallego Arroba. Servicio Andauz de Salud) ; Vilaseca, Josep Maria (Universitat de Barcelona. Facultat de Medicina i Ciències de la Salut) ; Quesada, Jose A. (Universidad Miguel Hernández. Departamento de Medicina Clínica) ; Universitat Autònoma de Barcelona
The purpose of this study was to identify clinical, analytical, and sociodemographic variables associated with the need for hospital admission in people over 50 years infected with SARS-CoV-2 and to assess whether diabetes mellitus conditions the risk of hospitalization. [...]
2022 - 10.3390/jcm11082092
Journal of clinical medicine, Vol. 11 Núm. 8 (april 2022) , p. 2092  
10.
27 p, 991.2 KB Cardiovascular preventive recommendations. PAPPS 2020 update Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2020 / Orozco-Beltrán, Domingo (Universidad Miguel Hernández de Elche) ; Brotons, Carlos (Institut d'Investigació Biomèdica Sant Pau) ; Alemán Sánchez, José Juan (Servicio Canario de la Salud) ; Banegas Banegas, José Ramón (Universidad Autónoma de Madrid) ; Cebrián-Cuenca, Ana M (Centro de Salud Cartagena Casco Antiguo) ; Gil-Guillén, Vicente F. (Universidad Miguel Hernández de Elche) ; Martín-Rioboó, Enrique (UGC Poniente en Córdoba Distrito Sanitario Córdoba Guadalquivir) ; Navarro-Pérez, Jorge F. (Instituto de Investigación INCLIVA) ; Universitat Autònoma de Barcelona
The recommendations of the semFYC's Program for Preventive Activities and Health Promotion (PAPPS) for the prevention of cardiovascular diseases (CVD) are presented. The following sections are included: Epidemiological review, where the current morbidity and mortality of CVD in Spain and its evolution as well as the main risk factors are described; Cardiovascular (CV) risk tables and recommendations for the calculation of CV risk; Main risk factors such as arterial hypertension, dyslipidemia and diabetes mellitus, describing the method for their diagnosis, therapeutic objectives and recommendations for lifestyle measures and pharmacological treatment; Indications for antiplatelet therapy, and recommendations for screening of atrial fibrillation. [...]
2020 - 10.1016/j.aprim.2020.08.002
Atencion Primaria, Vol. 52 (noviembre 2020) , p. 5-31  

Articles : 78 registres trobats   1 - 10següentfinal  anar al registre:
Documents de recerca 11 registres trobats  1 - 10següent  anar al registre:
1.
35.9 MB Estudio sobre los resultados de la adición de una sulfonilurea, un inhibidor de la dipeptidil peptidasa 4 (IDPP-4) o un inhibidor del cotransportador sodio-glucosa tipo 2 (ISGLT-2) como segundo antidiabético en pacientes con DM2 en tratamiento con metformina e insuficiente control glucémico. Estudio eControl Met+ / Vlacho, Bogdan ; Farre, Magi, dir. ; Franch Nadal, Josep, dir. ; Mundet-Tudurí, Xavier, dir.
A la pràctica clínica és molt comú afegir un segon fàrmac antidiabètic al tractament amb la metformina per millorar el control glucèmic i reduir els riscos de malaltia cardiovascular i renal entre els pacients amb diabetis mellitus tipus 2. [...]
En la práctica clínica es muy habitual añadir un segundo fármaco antidiabético al tratamiento con la metformina para mejorar el control glucémico y reducir los riesgos de enfermedad cardiovascular y renal entre los pacientes con diabetes mellitus tipo 2. [...]
In clinical practice, adding a second antidiabetic drug to metformin treatment is very common to improve glycemic control and reduce the risks of cardiovascular and renal disease among patients with type 2 diabetes mellitus. [...]

2022  
2.
34 p, 614.1 KB Evaluación del impacto de la infección por Strongyloides stercoralis sobre la diabetes mellitus tipo 2 / Galvis Andreu, Daniel ; Casal i Fàbrega, Jordi, dir. ; Universitat Autònoma de Barcelona. Facultat de Veterinària
La estrongiloidiasis es una enfermedad causada por Strongyloides stercoralis, un parásito capaz de autoinfectar y persistir en su hospedador. Suele ser asintomática y los casos graves suelen darse en inmunodeprimidos, aunque son poco frecuentes. [...]
2020
Màster Universitari en Zoonosi i Una Sola Salut (One Health) [1460]  
3.
159 p, 5.1 MB Diabetis mellitus tipus 1 : resistència a la insulina, rigidesa arterial i risc cardiovascular / Cano, Albert ; González-Clemente, José-Miguel, dir. ; Llauradó, Gemma, dir. ; Simó Canonge, Rafael, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
La diabetis mellitus tipus 1 (DM1) s'associa a una reducció de l'esperança de vida d'11 anys en homes i 13 anys en dones, i la malaltia cardiovascular (MCV) n'és la principal responsable. Els models de predicció del risc de MCV convencionals, derivats a partir de població general i amb diabetis mellitus tipus 2, subestimen el risc de MCV a la DM1. [...]
La diabetes mellitus tipo 1 (DM1) se asocia a una reducción de la esperanza de vida de 11 años en hombres y 13 años en mujeres, siendo la enfermedad cardiovascular (ECV) la principal responsable. Los modelos de predicción del riesgo de ECV convencionales, derivados de población general y con diabetes mellitus tipo 2, subestiman el riesgo de ECV en DM1. [...]
Type 1 diabetes mellitus (T1DM) remains a serious chronic disorder with an estimated life expectancy loss of about 11 years in men and 13 years in women, mainly due to cardiovascular disease (CVD). Conventional CVD risk scores, developed from the general population and people with type 2 diabetes, clearly underestimate CVD risk in T1DM. [...]

2021  
4.
103 p, 7.2 MB Retinopatia diabètica i gruix coroïdal com a factors associats a la malaltia ateroscleròtica subclínica en pacients amb diabetis mellitus tipus 1 sense antecedents previs de malaltia cardiovascular / Carbonell Puig, Marc ; Valldeperas Belmonte, Xavier, dir. ; Alonso Pedrol, Núria, dir. ; Mauricio Puente, Dídac, dir. ; Universitat Autònoma de Barcelona. Departament de Cirurgia
La retinopatía diabética (RD) es la principal complicación microvascular de los pacientes con diabetes mellitus (DM). Además, los pacientes con DM y RD presentan un riesgo aumentado de enfermedad cardiovascular (CV). [...]
Diabetic retinopathy (RD) is the main microvascular complication in patients with diabetes mellitus (DM). In addition, patients with DM and RD have an increased risk of cardiovascular (CV) disease. In this sense, CV disease due to atherosclerosis is the leading cause of morbidity and mortality in patients with DM. [...]

2020  
5.
166 p, 1.0 MB Efectivitat dels Inhibidors de l'Eix Renina-Angiotensina en pacients amb diabetis mellitus tipus 2 i hipertensió arterial a CATalunya. Estudi de cohorts IERACAT / Morros, Rosa ; Torrent Farnell, Josep, dir. (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Badia Llach, Xavier, dir. (Consorci Sanitari de Barcelona) ; Antonijoan Arbós, Rosa Ma., , dir. (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia
Objectius: Avaluar la morbiditat i la mortalitat dels pacients diabètics hipertensos tractats amb un inhibidor de l'enzim convertidor d'angiotensina (IECA) i / o un antagonista del receptor d'angiotensina II (ARAII) a Catalunya. [...]
[Barcelona] : Universitat Autònoma de Barcelona, 2017.  
6.
1 p, 715.9 KB iPSCs and their potential in the treatment of diabetes mellitus / Jamalizadeh Corominas, Edgar A. ; Ibáñez, Elena, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Biotecnologia [815]  
7.
175 p, 12.4 MB Biomarcadores de la inflamación en la diabetes mellitus tipo 2: Efecto del control glucémico y del fenotipo de las LDL / Vinagre Torres, Irene ; Pérez Pérez, Antonio, dir. ; De Leiva Hidalgo, Alberto, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
[Barcelona] : Universitat Autònoma de Barcelona, 2015  
8.
238 p, 1.9 MB Análisis de la dinámica del metabolismo hidrocarbonado / Benito Badorrey, Belén ; Franch-Nadal, Josep, dir. ; Mundet-Tudurí, Xavier, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
Objetivo: Determinar las variables clínicas asociadas al deterioro del metabolismo glucémico en población nomoglucémica con factores de riesgo para la diabetes mellitus tipo 2 (DM2) o prediabéticos.
Conclusiones: La incidencia de prediabetes entre los normoglucémicos fue del 17%, de DM2 entre los prediabéticos del 22,6% a los 5 años del seguimiento. Los factores identificados relacionados con la progresión a DM2 han sido la edad ≥60 años, colesterol y triglicéridos elevados. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2014  
9.
240 p, 4.2 MB Comparación del espesor macular entre niños diabéticos sin retinopatía diabética y niños sanos / Bañón Navarro, Raquel ; García Arumí, José, dir. ; Sorlí Clemente, Elena María, dir. ; Universitat Autònoma de Barcelona. Departament de Cirurgia
PROPÓSITO: Analizar la diferencia del espesor macular entre la población infantil y juvenil diabética sin retinopatía diabética respecto a la población infantil y juvenil no diabética. MATERIAL Y MÉTODOS: La muestra a estudio está constituida por 148 sujetos agrupados en cuatro grupos de 37 sujetos cada uno. [...]
PURPOSE: Analyzing the difference in macular thickness between pediatric and junior diabetic population without diabetic retinopathy, and the pediatric and junior not diabetic population. MATERIAL AND METHODS: The studied sample is composted by 148 people classified in four groups of 37 subjects each one. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2013  
10.
1 p, 345.9 KB Development of type 2 diabetes mellitus following intrauterine growth retardation / Crosa-Bonell, Mireia ; Bosch i Tubert, Fàtima (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2013
Grau en Biotecnologia [815]  

Documents de recerca : 11 registres trobats   1 - 10següent  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.